Role of Angiogenesis in IBD Pathogenesis

血管生成在 IBD 发病机制中的作用

• 批准号: 7280424
• 负责人: CLAUDIO FIOCCHI
• 金额: $ 30.76万
• 依托单位: CLEVELAND CLINIC LERNER COM-CWRU
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-15 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7280424
• 关键词: Angiogenic Factor; Animal Model; Animals; Arts; Autoimmune Process; Autoimmunity; Biological; Biological Factors; Categories; Cell Adhesion Molecules; Cell Communication; Cell Proliferation; Cells; Chronic; Clinical; Clinical Trials; Colitis; Communication; Complex; Data; Detection; Disease; Endopeptidases; Endothelial Cells; Evaluation; Extracellular Matrix; Extracellular Matrix Proteins; Gene Expression; Growth Factor; Human; Hyaluronan; Immune; Inflammation; Inflammatory; Inflammatory Bowel Diseases; Inflammatory disease of the intestine; Integrins; Intestines; Knowledge; Leukocytes; Malignant Neoplasms; Mediating; Mediator of activation protein; Microarray Analysis; Mucous Membrane; Mus; Pathogenesis; Patients; Peptide Hydrolases; Play; Prevention; Process; Role; Solid; Source; Testing; Therapeutic Effect; Tissues; Vascularization; angiogenesis; cell type; chemokine; concept; cytokine; density; migration; neoplastic; response

DESCRIPTION (provided by applicant): Inflammatory bowel disease (IBD) involves the interplay of multiple biological factors, among which nonimmune cells represent an underrated but crucial component of disease pachogenesis. In particular; mucosal endothelial cells play a key role in chronic inflammation through angiogenesis, a complex process mediated by the coordinated involvement of multiple cells types and a variety of sol nble mediators, which can be grouped into four major categories: a) growth factors, that directly promote endothelial cell proliferation and migration, b) integrins, adhesion molecules that allow communication of endothelial cells with other cells and the extracellular matrix (ECM), c) leukocytes, cytokines and chemokines, that drive immune-mediated endothelial cell activation, and d) proteolytic enzymes and ECM proteins, that are responsible for the tissue remodeling necessary to formation of new vessels. Sate-of-the-art knowledge on tie role of angiogenesis in cancer, autoimmunity and chronic inflammation, and our own preliminary data, obtained by studying tissues and cells from IBD patients and mice with experimental colitis, provide solid evidence supporting the concept that angiogenesis plays a vital role in initiation and perpetuation of intestinal inflammation. This proposal will investigate mechanisms of angiogenesis in IBD by testing the following central hypothesis: Angiogenesis is a critical component of IBD and contributes to disease pathogenesis. This hypothesis will be tested by four specific aims: 1) Obtain evidence of increased vascularization and endothelial cell activation in IBD mucosa; 2) Define the dominant angiogenic factors produced in IBD, their origin, and biological activity; 3) Characterize endothelial cell-mediated changes in the ECM that promote angiogenesis; 4) Investigate the therapeutic effects of anti-angiogenic compounds in animal models of IBD. Blocking angiogenesis may interrupt the chronic cycle of immune-nonimmune cell interactions occurring in IBD and result in clinical improvement, as suggested by clinical trials in humans and animals suffering from neoplastic, autoimmune and inflammatory disorders.

描述（由申请人提供）：炎症性肠病（IBD）涉及多种生物学因素的相互作用，其中非免疫细胞代表了被低估但至关重要的疾病 - 疾病生成成分。尤其; mucosal endothelial cells play a key role in chronic inflammation through angiogenesis, a complex process mediated by the coordinated involvement of multiple cells types and a variety of sol nble mediators, which can be grouped into four major categories: a) growth factors, that directly promote endothelial cell proliferation and migration, b) integrins, adhesion molecules that allow communication of endothelial cells with other cells and the extracellular matrix （ECM），C）驱动免疫介导的内皮细胞活化的白细胞，细胞因子和趋化因子，以及d）蛋白水解酶和ECM蛋白，这些蛋白是导致形成新容器所需的组织重塑的。关于血管生成在癌症，自身免疫性和慢性炎症中的领带作用的知识，以及我们自身的数据，通过研究IBD患者的组织和细胞和小鼠具有实验性结肠炎获得的良好证据，提供了支持血管生成在启动和无性炎症中起着至关重要的概念的良好证据。该建议将通过检验以下中心假设来研究IBD中血管生成的机制：血管生成是IBD的关键组成部分，并有助于疾病发病机理。该假设将通过四个特定目的进行检验：1）获得IBD粘膜中血管化和内皮细胞激活增加的证据； 2）定义IBD中产生的主要血管生成因子，其起源和生物学活性； 3）表征促进血管生成的ECM内皮细胞介导的变化； 4）研究IBD动物模型中抗血管生成化合物的治疗作用。阻塞血管生成可能会中断IBD中发生的免疫非免疫细胞相互作用的慢性周期，并导致临床改善，如人类和患有肿瘤，自身免疫性和炎症性疾病的人类和动物的临床试验所表明的那样。